Effect of Propranolol and IFN-β on the Induction of MHC Class II Expression and Cytokine Production by IFN-γ in THP-1 Human Monocytic Cells

References

• McFarlin D E, McFarland H F. Multiple sclerosis. N. Engl. J. Med. 1982; 307: 1183–1188, 1246–1251
   PubMed Web of Science ®Google Scholar
• Raine C. The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesions. Ann. Neural. 1994; 36(suppl.)S61–72
   Google Scholar
• Navikas V, Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 1996; 45: 322–333
   PubMed Web of Science ®Google Scholar
• Cannella B C, Raine C S. The adhesion molecules and cytokine profile of multiple sclerosis lesion. Ann. Neurol. 1995; 37: 424–435
   PubMed Web of Science ®Google Scholar
• Tsukada N, et al. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J. Neurosci. 1991; 102: 230–234
   Google Scholar
• Selmaj K, Raine C S, Cannella B, Brosnan C F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 1991; 87: 949–954
   PubMed Web of Science ®Google Scholar
• Selmaj K, Raine C. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988; 23: 339–346
   PubMed Web of Science ®Google Scholar
• Selmaj K, Farooq M, Norton W, et al. Proliferation of astrocytes in vitro in response to cytokines: A primary role for tumor necrosis factor. J. Immunol. 1990; 144: 129–135
   PubMed Web of Science ®Google Scholar
• Adams D O, Hamilton T A. The cell biology of macrophage activation. Ann. Rev. Immunol. 1984; 2: 283–318
   PubMed Web of Science ®Google Scholar
• Adams D O, Hamilton T A. Molecular transductional mechanisms by which IFN-y and other signals regulate macrophage development. Immunol. Rev. 1987; 97: 5
   PubMed Web of Science ®Google Scholar
• Adams D, Hamilton T. Molecular basis of macrophage activation: diversity and its origins. The Macrophage: The Natural Immune System, L Lewis, J McGee. IRL Press, Oxford 1992; 75–105
   Google Scholar
• Sen G C, Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 1992; 267: 5017–5020
   PubMed Web of Science ®Google Scholar
• Vassalli P. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 1992; 10: 411–452
   PubMed Web of Science ®Google Scholar
• Cannella B, Raine C S. Cytokines up-regulate Ia expression in organotypic cultures of CNS tissue. J. Neuroimmunol. 1989; 24: 239–248
   PubMed Web of Science ®Google Scholar
• Rieckmann P, et al. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 1995; 37: 82–88
   PubMed Web of Science ®Google Scholar
• Sharief M, Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 1991; 325: 467–472
   PubMed Web of Science ®Google Scholar
• Koide Y, Ina Y, Nezu N. Calcium influx and the calcium-calmodulin complex are involved in interferon-y-induced expression of HLA class II molecules on HL-60 cells. Proc. Natl. Acad. Sci. USA 1988; 85: 3120–3124
   PubMed Web of Science ®Google Scholar
• Fan X-D., Goldberg M, Bloom B R. Interferon-y-induced transcriptional activation is mediated by protein kinase C. Proc. Natl. Acad. Sci. USA 1988; 85: 5122–5125
   PubMed Web of Science ®Google Scholar
• Besta P V, et al. A p-adrenergic agonist modulates DRa gene transcription via enhanced cAMP levels in a glioblastoma multiforme line. J. Immunol. 1989; 142: 2895–2901
   PubMed Web of Science ®Google Scholar
• Celada A, Maki R A. IFN-y induces the expression of the genes for MHC class II I-Ab and tumor necrosis factor through a protein kinase C-independent pathway. J. Immunol. 1991; 146: 114–120
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693–698
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 1984; 225: 1365–1370
   PubMed Web of Science ®Google Scholar
• Majerus P W, et al. Recent insights in phosphatidylinositol signaling. cell 1990; 63: 459
   PubMed Web of Science ®Google Scholar
• Exton J H. Signaling through phosphatidylcholine breakdown. J. Biol. Chem. 1990; 265: 1–4
   PubMed Web of Science ®Google Scholar
• Exton J H. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1994; 1212: 26–42
   PubMed Web of Science ®Google Scholar
• Thompson N T, et al. Receptor-coupled phospholipase D and its inhibition. Trands Pharmacol. Sci. 1991; 12: 404–408
   PubMed Web of Science ®Google Scholar
• Noronha A, et al. Interferon-p decreases T cell activation and interferon-γ production in multiple sclerosis. J. Neuroimmunol. 1993; 46: 145–153
   PubMed Web of Science ®Google Scholar
• Rudick R A, et al. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology 1993; 43: 2080–2087
   PubMed Web of Science ®Google Scholar
• Khabar K SA. Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-α and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J. Leukoc. Biol. 1992; 52: 165–172
   PubMed Web of Science ®Google Scholar
• Barna B P, et al. Interferon-p impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J. Neuroimmunol. 1989; 23: 45–53
   PubMed Web of Science ®Google Scholar
• Ling P D, et al. Antagonistic effect of interferon-p on the interferon-y-induced expression of la antigen in murine macrophages. J. Immunol 1985; 135: 1857–1863
   PubMed Web of Science ®Google Scholar
• Inaba K, et al. Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigen. J. Exp. Med. 1986; 163: 1030–1035
   PubMed Web of Science ®Google Scholar
• Auwerx J. The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation. Experimentia 1991; 47: 22–30
   PubMedGoogle Scholar
• Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984; 23: 5036–5041
   PubMed Web of Science ®Google Scholar
• Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita P. Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem. Biophys. Res. Commun. 1986; 135: 397–402
   PubMed Web of Science ®Google Scholar
• Herbert J M, Seban E, Maffrand J P. Characterization of specific binding sites for [3H]-staurosporine on various protein kinases. Biochem. Biophys. Res. Commun. 1990; 171: 189–195
   PubMed Web of Science ®Google Scholar
• Gschwendt W, Horn F, Kittstein W, Fuerstenberg G, Besemfelder E, Marks F. Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds. Biochem. Biophys. Res. Commun. 1984; 124: 63–68
   Google Scholar
• Cheng K, Chan W W.S, Butler B, Barreto A J, Smith R G. Evidence for a role of protein kinase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells. Endocrinology 1991; 129: 3337–3342
   PubMed Web of Science ®Google Scholar
• Toullec D, Pianetti P, Coste H, Bellevergue P, et al. The bisindolylmaleimide GF 1092203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 1991; 266: 15771–15781
   PubMed Web of Science ®Google Scholar
• Davis P D, Elliott L H, Harris W, Hill C H, et al. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J. Med. Chem. 1992; 35: 994–1001
   PubMed Web of Science ®Google Scholar
• Veis N, Rosen A, Aderem A. Microtubule-active agents mimic lipopolysaccharides in priming macrophages for enhanced arachidonic acid metabolism. J. Inflamm. 1996; 46: 106–113
   PubMedGoogle Scholar
• Kramer R M, Checani G C, Deykin D. Stimulation of calcium-activated platelet phospholipase A2 by diacylglycerol. Biochem. J. 1987; 248: 779–783
   PubMed Web of Science ®Google Scholar
• Murakami K, Routtenberg A. Direct activation of purified protein kinase C by unsaturated fatty acids (oleate and arachidonate) in the absence of phospholipid and calcium. FEBS Lett. 1985; 192: 189
   PubMed Web of Science ®Google Scholar
• Fan X, et al. Arachidonic acid and related methyl ester mediate protein kinase C activation in intact platelets through the arachidonate metabolism pathways. Biochem. Biophys. Res. Commun. 1990; 169: 933
   PubMed Web of Science ®Google Scholar
• Dore-Duffy P, Donaldson J, Koff T, et al. Prostaglandin release in multiple sclerosis: correlation with disease activity. Neurology 1986; 36: 2593–2597
   Google Scholar
• Dore-Duffy P, Donovan C, Todd R FI. Expression of monocyte activation antigen Mo3 on the surface of peripheral blood monocytes from patients with multiple sclerosis. Neurology 1992; 42: 1609–1614
   PubMed Web of Science ®Google Scholar
• Merrill J, Strom S, Ellison G, et al. In vitro study of mediators of inflammation in multiple sclerosis. J. Clin. Immunol. 1989; 9: 84–96
   PubMed Web of Science ®Google Scholar
• Prineas J, Graham J. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin dreakdown. Ann. Neurol. 1981; 10: 149–158
   PubMed Web of Science ®Google Scholar
• Prineas J W, Wright R G. Macrophges, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 1978; 38: 409–418
   PubMed Web of Science ®Google Scholar
• Black D M, Catteral J R, Remington J S. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ. J Immunol 1987; 138: 491–495
   PubMed Web of Science ®Google Scholar
• Panitch H S, Hirsch R L, Schindler J, Johnson K P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893–895
   PubMed Web of Science ®Google Scholar
• Traugott U, Lebon P, Raine C S. Multiple sclerosis: Possible role of interferon gamma for reactivation of the disease process. J Neuropath Exp Neurol 1987; 46: 366–372
   Web of Science ®Google Scholar
• Beck J, Rondot P, Catinot L, et al. Increased production of interferon gamma and tumor necrosis factor in MS. Acta Neurologica Scand 1988; 78: 318–323
   PubMed Web of Science ®Google Scholar
• Traugott U, Lebon P. Multiple sclerosis: Involvement of interferons in lesion pathogenesis. Ann. Neurol. 1988; 24: 243–251
   PubMed Web of Science ®Google Scholar
• Li Q, Milo R, Bever C T, Swoveland P, Panitch H. Protein kinase C regulates HLA class II molecule expressions and TNF-α production in THP-1 cells. FASEB J. 1994; 8: A506
   Web of Science ®Google Scholar
• Li Q, Bever C T. Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C. Immunopharmacol. Immunotoxicol. 1996; 18: 375–396
   PubMed Web of Science ®Google Scholar
• Robbins D, Shirazi Y, Drysdale B, et al. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 1987; 139: 2593–2597
   PubMed Web of Science ®Google Scholar
• Durum S, Oppenheim J. Macrophage-derived mediators: interleukin-1, tumor necrosis factor, interleukin-6, and related cytokines. Fundamental immunology, W Paul. Raven Press, New York 1989; 639–661
   Google Scholar
• Old L. Polypeptide mediator network. Nature 1987; 326: 330–331
   PubMed Web of Science ®Google Scholar
• Soliven B, Szuchet S, Nelson D. Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes. J. Membrane Biol. 1991; 124: 127–137
   PubMed Web of Science ®Google Scholar
• Hofman F, Hinton D, Johnson K, et al. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 1989; 170: 607–612
   PubMed Web of Science ®Google Scholar
• Giulian D, Lachman L. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985; 228: 497–499
   PubMed Web of Science ®Google Scholar
• Interferon-β Multiple Sclerosis Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology 1993; 43: 662–667
   Google Scholar
• Cieri M, Bever C T. Gamma interferon induced increases in cathepsin B activity are blocked by alpha and beta interferons (Type I interferon). FASEB J. 1990; 4: A339
   Google Scholar
• Whitaker J N, Heineman M A, Uzman B G. The renal degradation of MBP peptide 43–88 by two enzymes in different subcellular fractions. Biochem J 1982; 201: 543–553
   PubMed Web of Science ®Google Scholar
• Berlet H H, Ilzenhofer H. Elucidation of cathepsin B-like activity associated with extracts of human myelin basic protein. FEBS Lett. 1985; 179: 299–302
   PubMed Web of Science ®Google Scholar
• Yanagisawa K, Sato S, Miyatake T, Kominami E, Katsunuma N. Degradation of myelin protein by cathepsin B and inhibition by E-64 analogue. Neurochem. Res. 1984; 9: 691–694
   PubMed Web of Science ®Google Scholar
• Garotta G, et al. Functional antagonism between type I and Type II interferons on human macrophages. Biochem. Biophys. Res. Commun. 1986; 140: 948–954
   PubMed Web of Science ®Google Scholar
• Alan R, et al. Interferon alpha/beta selectively antagonizes down-regulation of mannosyl-fucosyl receptors on activated macrophages by interferon gamma. Biochem. Biophys. Res. Commun. 1986; 136: 737–744
   PubMed Web of Science ®Google Scholar
• Unanue E, Beller D, Lu C, et al. Antigen presentation: comments on its regulation and mechanism. J. Immunol. 1984; 132: 1–4
   PubMed Web of Science ®Google Scholar
• Chou Y, Vainiene M, Whitham R, et al. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J. Neurosci. Res. 1989; 23: 207–216
   PubMed Web of Science ®Google Scholar
• Martin R, Jaraquemada D, Flerlage M, et al. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from mutiple sclerosis patients and healthy individuals. J. Immunol. 1990; 145: 540–548
   PubMed Web of Science ®Google Scholar
• Ota K, Matsui M, Milford E, et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183–187
   PubMed Web of Science ®Google Scholar
• Pette M, Fujita K, Wilkinson D, et al. Myelin autoreactivity in multiple sclerosis: recognition of myelin-basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 1990; 87: 7968–7972
   PubMed Web of Science ®Google Scholar
• Pitzurra L, Blasi E, Puliti M, Bistoni F. Toxic effects of tetanus toxin on GG2EE macrophages: prevention of gamma interferon-mediated upregulation of lysozyme-specific mRNA levels. Infect. Immun. 1993; 61: 3605–3610
   PubMed Web of Science ®Google Scholar
• Brown D, Faris M, Hilburger M, Zwilling B S. The induction of persistence of I-A expression by macrophages from Bcgr mice occurs via a protein kinase C-dependent pathway. J. Immunol. 1994; 152: 1323–1331
   PubMed Web of Science ®Google Scholar
• Sands W A, Clark J S, Liew F Y. The role of a phosphatidylcholine-specific phospholipase C in the production of diacylglycerol for nitric oxide synthesis in macrophages activated by IFN-γ and LPS. Biochem. Biophys. Res. Commun. 1994; 199: 461–466
   PubMed Web of Science ®Google Scholar
• Politis A D, Sivo J, Vogel S N. Multiple pathways of interferon-induced gene expression in murine macrophages. J. Leukoc. Biol. 1993; 53: 583–590
   PubMed Web of Science ®Google Scholar
• Jun C D, Choi B M, Kim H M, Chung H T. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages. J. Immunol. 1995; 154: 6541–6547
   PubMed Web of Science ®Google Scholar
• Suk K, Somers S D, Erickson K L. Regulation of murine macrophage function by IL-4: IL-4 and IFN-γ differentially regulate macrophage tumoricidal activation. Immunology 1993; 80: 617–624
   PubMed Web of Science ®Google Scholar
• Sands W A, Bulut V, Severn A, Xu D, Liew F Y. Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. Eur. J. Immunol. 1994; 24: 2345–2350
   PubMed Web of Science ®Google Scholar
• Weiel J E, Adams D O, Hamilton T A. Biochemical models of gamma- interferon action: altered expression of transferrin receptors on murine peritoneal macrophages after treatment in vitro with PMA or A23187. J. Immunol. 1985; 134: 293–298
   PubMed Web of Science ®Google Scholar
• Celada A, Schreiber R D. Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-y. J. Immunol. 1986; 137: 2373–2379
   PubMed Web of Science ®Google Scholar
• Somers S C, Weiel J E, Hamilton T A, Adams D O. Phorbol esters and calcium ionophore can prime murine peritoneal macrophages for tumor cell destruction. J. Immunol. 1986; 136: 4199–4205
   PubMed Web of Science ®Google Scholar
• Gumina R J, Freire-Moar J, DeYoung L, Webb D, Devens B H. Transduction of the IFN-y signal for HLA-DR expression in the promonocytic line THP-1 involves a late acting PKC activity. Cell. Immunol. 1991; 138: 265–279
   PubMed Web of Science ®Google Scholar
• Benveniste E N, Vidovic M, Panek R B, Norris J G, Reddy A T, Benos D J. Interferon-y-induced astrocyte class II major histocompatibility complex gene expression is associated with both protein kinase C and activation and Na+ entry. J. Biol. Chem. 1991; 266: 18119–18126
   PubMed Web of Science ®Google Scholar
• Politis A D, Vogel S N. Pharmacologic evidence for the requirement of protein kinase C in IFN-induced macrophage Fcy receptor and Ia antigen expression. J. Immunol. 1990; 145: 3788–3795
   PubMed Web of Science ®Google Scholar
• Nezu N, et al. Regulation of HLA class II molecule expressions by IFN-γ: The signal transduction mechanism in glioblastoma cell lines. J. Immunol. 1990; 145: 3126–3135
   PubMed Web of Science ®Google Scholar
• Mattila P, Hayry P, Renkonen R. Protein kinase C is crucial in signal transduction during gamma-interferon induction in endothelial cells. FEBS Lett. 1989; 250: 362–366
   PubMed Web of Science ®Google Scholar
• Yoshida A, Koide Y, Uchijima M, Yoshida T O. IFN-y induces IL-12 mRNA expression by a murine macrophage cell line, 1774. Biochem. Biophys. Res. Commun. 1994; 198: 857–861
   PubMed Web of Science ®Google Scholar
• Muller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK complements defects in interferon alpha/beta and gamma signal transduction. Nature 1993; 366: 129–135
   PubMed Web of Science ®Google Scholar
• Watling D, Guschin D, Muller M, et al. Complementation by the protein tyrosine kinase Jak 2 of a mutant cell line defective in the interferon-y signal transduction pathway. Nature 1993; 366: 166–170
   PubMed Web of Science ®Google Scholar
• Igarashi K, Garotta G, Ozmen L, et al. Interferon-γ induces tyrosine phosphorylation of the interferon-Y receptor and the regulated association of the protein tyrosine kinases, Jak1 and Jak2, with its receptor. J. Biol. Chem. 1994; 269: 14333
   PubMed Web of Science ®Google Scholar
• Darnell J E, Kerr I M, Stark G R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415–1421
   PubMed Web of Science ®Google Scholar
• Meyer T, Regenass U, Fabbro D, et al. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti- proliferative as well as in vivo anti-tumor activity. Int. J. Cancer 1989; 43: 851–856
   PubMed Web of Science ®Google Scholar